Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program

J Rheumatol. 2023 May;50(5):718. doi: 10.3899/jrheum.221022.C1.
No abstract available

Publication types

  • Published Erratum